Review Article
Enteroviral Infections in Primary Immunodeficiency (PID): A Survey of Morbidity and Mortality

https://doi.org/10.1053/jinf.2002.1066Get rights and content

Abstract

We have explored the natural history of enteroviral infection in patients with primary antibody deficiency by surveying both published and unpublished case reports before the new anti-enteroviral drug, pleconaril, was available. Many different enteroviruses were involved, Echovirus 11 being the most common. The central nervous system was nearly always involved, with evidence of systemic involvement of muscle and/or liver and/or joints in about 40% of patients. Neurological symptoms and signs varied with minor or no changes in the cerebro-spinal fluid. There was high morbidity and mortality; a third of polio cases (usually vaccine related), and nearly half of non-polio infected patients died; about 40% of survivors of the initial illness had long-term neurological symptoms. Prophylactic immunoglobulin therapy did not prevent infection but these patients were on lower doses as compared to current recommendations. Our data provides a useful background for assessing the efficacy of new anti-viral treatment in this condition.

References (15)

There are more references available in the full text version of this article.

Cited by (95)

  • Infections in primary immunodeficiency

    2022, Allergic and Immunologic Diseases: A Practical Guide to the Evaluation, Diagnosis and Management of Allergic and Immunologic Diseases
  • 63 - Primary Immunodeficiency and Other Diseases With Immune Dysregulation

    2019, Kendig's Disorders of the Respiratory Tract in Children
View all citing articles on Scopus
f1

Please address all correspondence to: A. D. B. Webster, Department of Immunology, Royal Free Hospital, Pond Street, London, NW3 2QG. Tel.: +2078302141; Fax: +2078302224; E-mail address:[email protected] (A. D. B. Webster).

View full text